VivoSeq
Ophthalmology

Dry Eye Symptoms

0

Pipeline Programs↗

1

Active Trials↗

2

Companies Involved↗

Dry Eye Symptoms is an early-stage landscape with 0 programs across 2 companies. The most active players are Trima, Israel Pharmaceutical Products, AbbVie.

Intelligence

Pipeline Metrics

Competitive Density

6/100

Pipeline Velocity

0/100

Mech. Concentration

N/A

Completion Rate

100/100

Attrition Rate

0/100

Competition

Competitive Landscape

Bubble size = clinical trials

Approved
Phase 3
Phase 2
Phase 1
Preclinical

Key Players

Top Companies Companies ranked by the number of pipeline programs they run for this disease.

T

Trima, Israel Pharmaceutical Products

0 programs

PreclinicalAbbVie logo

AbbVie

0 programs

Preclinical

Pipeline

Programs by Phase

No pipeline programs currently tracked for this disease.

Analysis

Trial Status

10

clinical trials

Completed8 · 80%
Unknown status1 · 10%
Recruiting1 · 10%

Clinical Trials

Trial Activity

10 trials

Assessment of CataClear, Tear Film Stability, Tear Volume, and Dry Eye Symptoms Using Stem Cells Fortified Eye Drops
Recruiting·AAce Cells Lab Limited·Phase 4·NCT07191847·300 enrolled
Evaluation of Blink Tears and Systane Concomitant With Restasis for the Treatment of Dry Eye Symptoms
Completed·MMedical University of South Carolina·N/A·NCT00565669·20 enrolled
Efficacy of Cyclosporine for the Prevention and Treatment of Dry Eye Symptoms Following LASIK or Photorefractive Keratectomy
Completed·IInnovative Medical·Phase 4·NCT00349440·93 enrolled
Efficacy of Optive Versus Systane Concomitant With Restasis (Cyclosporine A) for the Treatment of Dry Eye Symptoms
Completed·IInnovative Medical·Phase 4·NCT00399061·55 enrolled
Can Pregabalin Reduce the Frequency and Severity of Dry Eye Symptoms After Laser-assisted in Situ Keratomileusis?
Completed·UUniversity of Miami·Phase 2/3·NCT02701764·43 enrolled
Study to Assess the Safety and Patients' Satisfaction of Tears Again* in the Treatment of Dry Eye Symptoms
Completed·TTrima, Israel Pharmaceutical Products·N/A·NCT00535054·125 enrolled
A Clinical Evaluation Pilot Study of the Efficacy of Blink® Tears Lubricant Eye Drops for the Relief of Dry Eye Symptoms Following Implantation of Tecnis® Multifocal Introcular Lens
Completed·IInnovative Medical·Phase 4·NCT01061268·25 enrolled
A Study to Determine the Relief of Dry Eye Symptoms With the Use of TheraTears® Products (DUNLIN)
Completed·UUniversity of Waterloo·Phase 4·NCT02014922·33 enrolled
Performance and Acceptance of Optive Versus Hylocomod Eyedrops in Patients With Dry Eye Symptoms
Completed·AbbVie logoAbbVie·Phase 4·NCT00761202·50 enrolled
Diquafosol Ophthalmic Solution for Dry Eye Symptoms
Unknown status·HHe Eye Hospital·N/A·NCT04980144·101 enrolled

Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)